Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 23 hours ago

Indications

Felbinac is used to relieve the symptoms of painful inflammatory conditions of the muscles, bones and joints. These include soft tissue injuries such as sprains, strains and contusions. It is also used for inflammatory or rheumatic conditions that sit outside the joint itself, including bursitis, capsulitis, frozen shoulder, myalgia, tendonitis, tenosynovitis and tennis elbow. Felbinac also helps with the pain and stiffness of rheumatic or non-serious arthritic conditions (that is, common arthritis).

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Felbinac works mainly by blocking the cyclooxygenase (COX) enzymes, both COX-1 and COX-2. These enzymes are needed for the body to make prostaglandins, which are lipid compounds involved in inflammation, pain and fever. When Felbinac blocks the COX enzymes, less prostaglandin is produced. That calms the inflammatory response and eases pain.

Pregnancy & Breastfeeding

Felbinac is suspected to cause serious birth defects when it is used during pregnancy, so Traxam 3% w/w Gel must not be used in pregnancy. Like other non-steroidal anti-inflammatory agents, which inhibit prostaglandin synthesis, felbinac caused dystocia and delayed parturition in animal studies when it was given subcutaneously.

Traxam 3% w/w Gel should not be used during breast-feeding. It is contraindicated at this time too.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Rub 1 gm of Felbinac gel lightly into the affected area 2 to 4 times a day. If the symptoms don't resolve, the patient should be reviewed to assess whether continued treatment is appropriate. The total dose should not exceed 25 g a day, regardless of the number of affected areas. Treatment should not go beyond 6 weeks. Elderly: No special dosage recommendations are made for elderly patients. However, NSAIDs should be used with particular caution in the elderly, who are more prone to adverse events. The lowest dose compatible with adequate safe clinical control should be used. Paediatric population: There is insufficient information about the safety and efficacy of this medicine in children. It is not recommended for children under 18 yrs. Method of administration: Topical to the affected area. Hands should be washed after applying Felbinac 3% Gel, unless they are the treatment sites.